Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Oncoimmunology|June 28, 2012
Activation of antigen-exposed iMC-DCs at the "right place" and "right time" promotes potent anti-tumor immunityDavid M SpencerCell Cycle (Georgetown, Tex.)|February 3, 2009
Paths of FGFR-driven tumorigenesisVictor D Acevedo, Michael Ittmann, David M SpencerUrologic Oncology|December 1, 2007
Vaccine therapy for prostate cancerGuru Sonpavde, David M Spencer, Kevin M SlawinCancer Research|December 26, 2003
Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate systemAlexander V Kazansky, David M Spencer, Norman M GreenbergThe Journal of Biological Chemistry|October 26, 2002
Activation of initiator caspases through a stable dimeric intermediateMin Chen, Aaron Orozco, David M Spencer, et al.Molecular Endocrinology (Baltimore, Md.)|December 20, 2003
The EZC-prostate model: noninvasive prostate imaging in living miceXiaoming Xie, Zheng Luo, Kevin M Slawin, et al.Cancer Research|June 17, 2006
EZC-prostate models offer high sensitivity and specificity for noninvasive imaging of prostate cancer progression and androgen receptor actionMamatha R Seethammagari, Xiaoming Xie, Norman M Greenberg, et al.Reviews in Urology|April 30, 2010
Emerging vaccine therapy approaches for prostate cancerGuru Sonpavde, Kevin M Slawin, David M Spencer, et al.Nature Biotechnology|December 5, 2006
An essential role for Akt1 in dendritic cell function and tumor immunotherapyDongsu Park, Natalia Lapteva, Mamatha Seethammagari, et al.Plos One|October 15, 2016
MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine ImmunogenicityMatthew R Collinson-Pautz, Kevin M Slawin, Jonathan M Levitt, et al.Pageof 6